August 2020 Issue Table Of Contents

From The Editor

• Leading Through Crisis

Feature Articles

• From Food To Pharma — Andrea Pfeifer’s Trek To Cure Alzheimer’s
• Driving Diversity And Inclusion In Life Sciences

Capitol Perspectives

• Democratic House Passes Rx Price Controls Amid Pandemic

CEO Corner

• 5 Considerations When Moving From Big Pharma To Biotech

Companies To Watch

• Cidara Therapeutics

From Policy to Execution

• The Politicizing Of Healthcare Vs. Principled Public Health Policy

Industry Research

• Small & Emerging Outsourced Manufacturing Activities

Inside The Industry

• Trends In Bioprocessing CDMO Selection
• The Co-Opportunities Of COVID-19
• COVID-19's Effect On Life Science Litigation
• It’s Past Time To Retake Control Of America’s Drug Supply
• One Heart Surgeon’s Journey From The OR To The C-Suite
• How To Overcome Bottlenecks To Expedite Drug Approvals
• Demystifying AI In Pharma

Leadership Lessons

• ROI Of Thought — A New Paradigm For What Matters

Ask The Board

• What Will Be The Three Greatest Learnings From The First Half Of 2020 That Will Change The Biopharma Industry Going Forward?
• What Advice Do You Have To Someone Beginning A Biopharma Job Search During These Unprecedented Times?
• What Has Been The Greatest Biopharma Business-Related Insight You Have Gained From Continued Operations During The First Half Of This Year?